Attached files

file filename
10-K - 10-K - Cardiff Oncology, Inc.trov-123119x10k.htm
EX-32.2 - EXHIBIT 32.2 - Cardiff Oncology, Inc.exhibit322q42019.htm
EX-31.2 - EXHIBIT 31.2 - Cardiff Oncology, Inc.exhibit312q42019.htm
EX-31.1 - EXHIBIT 31.1 - Cardiff Oncology, Inc.exhibit311q42019.htm
EX-23.1 - EXHIBIT 23.1 - Cardiff Oncology, Inc.exhibit231q42019.htm
EX-4.16 - EXHIBIT 4.16 - Cardiff Oncology, Inc.exhibit416q42019.htm


Exhibit 32.1
 
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Trovagene, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas H. Adams, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
2/27/2020
/s/ Thomas H. Adams
 
 
 
Thomas H. Adams
 
Chief Executive Officer (Principal Executive Officer)